Laura Rosiñol Selected Research

Cytokines

9/2011	Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide.
5/2002	Interleukin 6 and tumour necrosis factor alpha serum levels in monoclonal gammopathy of undetermined significance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura Rosiñol Research Topics

Disease

85	Multiple Myeloma 06/2022 - 05/2002
11	Neoplasms (Cancer) 01/2022 - 07/2004
9	Disease Progression 01/2021 - 01/2005
8	Monoclonal Gammopathy of Undetermined Significance 10/2021 - 05/2002
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 01/2018
6	Plasmacytoma 01/2022 - 05/2004
6	Immunoglobulin Light-chain Amyloidosis 12/2021 - 02/2008
6	Residual Neoplasm 09/2021 - 01/2012
6	Smoldering Multiple Myeloma 01/2018 - 09/2005
5	Paraproteinemias (Monoclonal Gammopathy) 04/2021 - 03/2003
4	Infections 01/2022 - 01/2005
4	Amyloidosis 12/2017 - 10/2012
4	Pathologic Complete Response 01/2014 - 12/2009
3	Lymphoma (Lymphomas) 01/2021 - 01/2012
3	Peripheral Nervous System Diseases (PNS Diseases) 09/2013 - 08/2004
2	Thrombocytopenia (Thrombopenia) 02/2022 - 01/2016
2	Pneumonia (Pneumonitis) 02/2022 - 01/2016
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 02/2022 - 01/2020
2	Neutropenia 02/2022 - 08/2016
2	Waldenstrom Macroglobulinemia (Macroglobulinemia) 04/2021 - 04/2003
2	Bronchiolitis Obliterans Syndrome 02/2021 - 11/2008
2	Fever (Fevers) 01/2020 - 01/2020
2	Crohn Disease (Crohn's Disease) 10/2017 - 01/2016
2	Renal Insufficiency (Renal Failure) 01/2005 - 08/2004
1	COVID-19 02/2022
1	Heart Failure 02/2022
1	Pancytopenia 02/2022
1	Circulating Neoplastic Cells 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 12/2021
1	Thrombotic Microangiopathies 01/2021
1	Genomic Instability 01/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2021
1	Inflammation (Inflammations) 12/2020
1	Sepsis (Septicemia) 01/2020

Drug/Important Bio-Agent (IBA)

22	Dexamethasone (Maxidex)FDA LinkGeneric 06/2022 - 01/2005
19	Bortezomib (Velcade)FDA Link 12/2021 - 01/2005
14	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
13	Lenalidomide (CC 5013)FDA Link 02/2022 - 08/2013
11	Thalidomide (Thalomid)FDA Link 01/2021 - 03/2003
9	Melphalan (Alkeran)FDA LinkGeneric 11/2021 - 01/2005
8	carfilzomibIBA 06/2022 - 01/2015
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2012
5	Proteasome InhibitorsIBA 02/2022 - 01/2005
5	Prednisone (Sone)FDA LinkGeneric 10/2018 - 11/2010
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 08/2012
4	Pharmaceutical PreparationsIBA 12/2020 - 07/2004
3	Nerve Growth Factor (NGF)IBA 01/2021 - 10/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2005
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 08/2004
3	Oligoclonal BandsIBA 08/2017 - 12/2009
3	Immunoglobulins (Immunoglobulin)IBA 07/2012 - 01/2011
2	Monoclonal AntibodiesIBA 06/2022 - 06/2012
2	pomalidomideIBA 02/2022 - 05/2019
2	daratumumabIBA 01/2022 - 01/2020
2	ParaproteinsIBA 01/2022 - 05/2019
2	Immunoglobulin M (IgM)IBA 04/2021 - 12/2017
2	Biological ProductsIBA 01/2021 - 01/2020
2	Immunomodulating AgentsIBA 12/2020 - 10/2017
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 02/2008
2	Immunoglobulin G (IgG)IBA 10/2018 - 11/2010
2	Immunoglobulin Light Chains (Immunoglobulin Light Chain)IBA 06/2018 - 01/2012
2	MicroRNAs (MicroRNA)IBA 01/2015 - 07/2012
2	CytokinesIBA 09/2011 - 05/2002
2	Cytotoxins (Cytolysins)IBA 01/2011 - 01/2005
2	Busulfan (Busulfex)FDA Link 11/2010 - 12/2007
2	Diphosphonates (Bisphosphonates)IBA 03/2010 - 10/2008
1	isatuximabIBA 06/2022
1	melflufenIBA 02/2022
1	Protein Isoforms (Isoforms)IBA 01/2022
1	Immunoglobulin A (IgA)IBA 01/2022
1	Serum AlbuminIBA 01/2022
1	B-Cell Maturation AntigenIBA 12/2021
1	Chimeric Antigen ReceptorsIBA 12/2021
1	Amyloid (Amyloid Fibrils)IBA 12/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 12/2021
1	Etoposide (VP 16)FDA LinkGeneric 01/2021
1	Clarithromycin (Biaxin)FDA LinkGeneric 01/2021
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2021
1	cadherin 5IBA 12/2020
1	NectinsIBA 01/2020
1	FluoroquinolonesIBA 01/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2020
1	poliovirus receptorIBA 01/2020

Therapy/Procedure

38	Therapeutics 02/2022 - 07/2004
31	Stem Cell Transplantation 12/2021 - 10/2007
8	Transplantation 01/2022 - 11/2008
8	Hematopoietic Stem Cell Transplantation 01/2021 - 12/2009
4	Autologous Transplantation 07/2013 - 02/2008
4	Drug Therapy (Chemotherapy) 07/2013 - 12/2005
2	Patient Readmission 01/2020 - 01/2020
2	Aftercare (After-Treatment) 12/2017 - 11/2016
2	Induction Chemotherapy 01/2011 - 11/2010
1	Kidney Transplantation 11/2021
1	Hemodilution 09/2021
1	Ambulatory Care (Outpatient Care) 01/2020
1	Antibiotic Prophylaxis 01/2020